Your browser doesn't support javascript.
loading
Current Challenges and Perspectives in Breast Cancer in Elderly Women: The Senologic International Society (SIS) Survey.
Scheer, Louise; Lodi, Massimo; Özmen, Tolga; Alghamdi, Khalid; Anyanwu, Stanley; Birendra, Joshi; Boubnider, Mohsen; Costa, Mauricio; Dian, Darius; Elder, Elisabeth; Gebrim, Luiz Henrique; Guo, Xiaojing; Heitz, Damien; Imoto, Shigeru; Ioannidou-Mouzaka, Lydia; Kaufman, Cary; Liu, Hong; Mbodj, Mamadou; Meka, Esther; Mundinger, Alexander; Novelli, Jorge; Ojuka, Daniel; Orda, Ruben; Ostapenko, Valerijus; Pienkowski, Tadeusz; Podolski, Paula; Vogel, Thomas; Yin, Jian; Özmen, Vahit; Schneebaum, Schlomo; Mathelin, Carole.
Afiliação
  • Scheer L; Service des équipes transverses et d'oncogériatrie, ICANS, Strasbourg, France.
  • Lodi M; Strasbourg University Hospital, Strasbourg, France; Institut de Cancérologie Strasbourg Europe (ICANS), Strasbourg Cedex, France; Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), CNRS, Université de Strasbourg, Illkirch-Graffenstaden, France.
  • Özmen T; Massachusetts General Hospital, Boston, United States.
  • Alghamdi K; King Abdulaziz University, Jeddah, Saudi Arabia.
  • Anyanwu S; Institute of Oncology, Nnamdi Azikiwe University Nnewi Campus, Nnewi, Nigeria.
  • Birendra J; Tribhuvan University Teaching Hospital, Kathmandu, Nepal.
  • Boubnider M; Centre Pierre et Marie Curie, Alger, Algeria.
  • Costa M; National Academy of Medicine, Rio de Janeiro, Brazil.
  • Dian D; AWOgyn, Berlin, Germany.
  • Elder E; Westmead Breast Cancer Institute, Westmead, Australia.
  • Gebrim LH; Hospital Pérola Byington, São Paulo, Brazil.
  • Guo X; Tianjin Medical University Cancer Institute & Hospital, Tianjin, China.
  • Heitz D; Institut de cancérologie Strasbourg Europe (ICANS), Strasbourg Cedex, France.
  • Imoto S; Kyorin University Hospital, Tokyo, Japan.
  • Ioannidou-Mouzaka L; Hellenic Senologic Society, Greece.
  • Kaufman C; University of Washington, Seattle, Washington, USA.
  • Liu H; Tianjin Medical University Cancer Institute & Hospital, Tianjin, China.
  • Mbodj M; CHU de Dakar, Sénégal.
  • Meka E; University of Yaoundé, Cameroon.
  • Mundinger A; Breast Imaging and Interventions; Breast Centre Osnabrück; FHH Niels-Stensen-Kliniken; Franziskus-Hospital Harderberg, Georgsmarienhütte, Germany.
  • Novelli J; Argentine Society of Mastology, Argentina.
  • Ojuka D; University of Nairobi, Nairobi, Kenya.
  • Orda R; Chairman of the International School of Senology of Sis, Israel.
  • Ostapenko V; National Cancer Institute, Vilnius, Lithuania.
  • Pienkowski T; Oncology and Breast Diseases Dept, Poland.
  • Podolski P; Croatian Senologic Society, Croatia.
  • Vogel T; Department of Geriatric, Strasbourg University Hospital, 1 place de l'hôpital, Strasbourg, France.
  • Yin J; Tianjin Medical University Cancer Institute & Hospital, Tianjin, China.
  • Özmen V; Istanbul Florence Nightingale Hospital, Istanbul, Turkey.
  • Schneebaum S; Department of Surgery, Tel Aviv Sourasky Medical Center, Tel Aviv Yafo, Israel.
  • Mathelin C; Strasbourg University Hospital, Strasbourg, France; Institut de Cancérologie Strasbourg Europe (ICANS), Strasbourg Cedex, France; Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), CNRS, Université de Strasbourg, Illkirch-Graffenstaden, France.
Eur J Breast Health ; 19(3): 201-209, 2023 Jul.
Article em En | MEDLINE | ID: mdl-37415654
Objective: Mammographic screening and management of breast cancer (BC) in elderly women are controversial and continue to be an important health problem. To investigate, through members of the Senologic International Society (SIS), the current global practices in BC in elderly women, highlighting topics of debate and suggesting perspectives. Materials and Methods: The questionnaire was sent to the SIS network and included 55 questions on definitions of an elderly woman, BC epidemiology, screening, clinical and pathological characteristics, therapeutic management in elderly women, onco-geriatric assessment and perspectives. Results: Twenty-eight respondents from 21 countries and six continents, representing a population of 2.86 billion, completed and submitted the survey. Most respondents considered women 70 years and older to be elderly. In most countries, BC was often diagnosed at an advanced stage compared to younger women, and age-related mortality was high. For this reason, participants recommended that personalized screening be continued in elderly women with a long life expectancy.In addition, this survey highlighted that geriatric frailty assessment tools and comprehensive geriatric evaluations needed to be used more and should be developed to avoid undertreatment. Similarly, multidisciplinary meetings dedicated to elderly women with BC should be encouraged to avoid under- and over-treatment and to increase their participation in clinical trials. Conclusion: Due to increased life expectancy, BC in elderly women will become a more important field in public health. Therefore, screening, personalized treatment, and comprehensive geriatric assessment should be the cornerstones of future practice to avoid the current excess of age-related mortality. This survey described, through members of the SIS, a global picture of current international practices in BC in elderly women.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article